Enovix (NASDAQ:ENVX) Stock Rating Upgraded by Wall Street Zen

Enovix (NASDAQ:ENVX) was upgraded by analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Sunday, Wall Street Zen reports.

ENVX has been the topic of several other research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $25.00 price target on shares of Enovix in a report on Thursday, August 13th. William Blair lowered Enovix from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. TD Cowen raised Enovix to a “hold” rating in a report on Monday, October 5th. Loop Capital upgraded shares of Enovix to a “strong-buy” rating in a research report on Monday, August 17th. Finally, Canaccord Genuity Group decreased their price objective on shares of Enovix from $15.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Enovix presently has an average rating of “Moderate Buy” and a consensus price target of $11.77.

Enovix Stock Up 5.3%

ENVX opened at $2.59 on Friday. The firm has a market capitalization of $568.37 million, a P/E ratio of -3.20 and a beta of 2.49. Enovix has a one year low of $2.40 and a one year high of $14.21. The company has a fifty day moving average price of $3.33 and a 200-day moving average price of $5.09. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37.

Enovix (NASDAQ:ENVX) last issued its quarterly earnings data on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The company had revenue of $9.02 million for the quarter, compared to the consensus estimate of $8.43 million. During the same quarter last year, the business posted ($0.13) earnings per share. The firm’s revenue was up 20.8% compared to the same quarter last year. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Equities research analysts expect that Enovix will post -0.80 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. NewEdge Advisors LLC grew its holdings in shares of Enovix by 4.7% during the 1st quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock valued at $215,000 after purchasing an additional 1,853 shares during the last quarter. Wealthfront Advisers LLC raised its position in Enovix by 27.8% in the 1st quarter. Wealthfront Advisers LLC now owns 13,800 shares of the company’s stock worth $71,000 after purchasing an additional 3,001 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in Enovix in the 4th quarter worth $30,000. Harbor Investment Advisory LLC raised its position in Enovix by 32.5% in the 2nd quarter. Harbor Investment Advisory LLC now owns 18,740 shares of the company’s stock worth $114,000 after purchasing an additional 4,600 shares during the period. Finally, USAdvisors Wealth Management LLC lifted its stake in Enovix by 50.0% in the first quarter. USAdvisors Wealth Management LLC now owns 15,000 shares of the company’s stock worth $73,000 after purchasing an additional 5,000 shares during the last quarter. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Key Enovix News

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Preliminary Q3 revenue reached approximately $11 million, up 38% year over year and above the company’s $11 million guidance and the roughly $9.5 million analyst consensus. The results suggest Enovix is continuing to expand commercial shipments. Enovix Q3 Preliminary Revenue Rises 38%
• Positive Sentiment: Defense demand and an expanding customer pipeline were highlighted as growth drivers. Investors may view increased defense-sector interest as validation for Enovix’s battery technology and a potential source of future orders. Enovix reports $11 million Q3 revenue
• Positive Sentiment: The company’s updated third-quarter outlook called for revenue of $11 million and an EPS loss of approximately $0.14, both better than consensus estimates of $9.5 million and a $0.16 loss, respectively. Enovix Q3 Revenue Rises 38% to $11 Million, Exceeding Guidance as Defence Demand Grows
• Neutral Sentiment: Market coverage noted that ENVX shares gained early in the session, reflecting the favorable preliminary revenue update; however, the stock remains highly volatile and well below its longer-term moving averages. US Stocks Mixed; Enovix Shares Jump
• Negative Sentiment: Wall Street Zen recently downgraded Enovix to “Sell,” underscoring continuing concerns about profitability, execution and the company’s substantial cash needs despite the improved revenue outlook. Enovix Raised to Sell at Wall Street Zen

About Enovix

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.